Armistice Capital, LLC Biora Therapeutics, Inc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.13 - $12.03 $1.09 Million - $101 Million	8,367,271 New	8,367,271 $1.09 Million
Q3 2021 Nov 15, 2021	SELL	$0.67 - $3.41 $5.09 Million - $25.9 Million	-7,597,166 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $10.5 Million - $24.5 Million	4,974,789 Added 189.71%	7,597,166 $27.1 Million
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $10.3 Million - $19.2 Million	2,622,377 New	2,622,377 $12.5 Million
Q4 2020 Feb 16, 2021	SELL	$3.27 - $9.48 $1.31 Million - $3.79 Million	-400,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.71 - $10.79 $3.08 Million - $4.32 Million	400,000 New	400,000 $3.61 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.